Phillips Lawrence | Laboratory Of Pharmaceutical Chemistry Developmental Therapeutics Program Division Of Cancer Treatme
スポンサーリンク
概要
- PHILLIPS Lawrence R.の詳細を見る
- 同名の論文著者
- Laboratory Of Pharmaceutical Chemistry Developmental Therapeutics Program Division Of Cancer Treatmeの論文著者
関連著者
-
Phillips Lawrence
Laboratory Of Pharmaceutical Chemistry Developmental Therapeutics Program Division Of Cancer Treatme
-
Wolfe Tracy
Drug Formulation Laboratory Science Applications International Company National Cancer Institute Fre
-
EZENNIA E.
Drug Formulation Laboratory, Science Applications International Company, National Cancer Institute,
-
PHILLIPS Lawrence
Laboratory of Pharmaceutical Chemistry, Division of Cancer Treatment and Diagnosis Centers, National
-
TABIBI S.
Pharmaceutical Resources Branch, National Cancer Institute
-
Tabibi S.
Pharmaceutical Resources Branch National Cancer Institute
-
Ezennia E.
Drug Formulation Laboratory Science Applications International Company National Cancer Institute Fre
-
Phillips Lawrence
Laboratory Of Pharmaceutical Chemistry Division Of Cancer Treatment And Diagnosis Centers National C
-
LUNN George
Program Resources, Inc./DynCorp. Laboratory of Pharmaceutical Chemistry, NCI-Frederick Cancer Resear
-
PACULA-COX Christine
Laboratory of Pharmaceutical Chemistry, Developmental Therapeutics Program, Division of Cancer Treat
-
Pacula-cox Christine
Laboratory Of Pharmaceutical Chemistry Developmental Therapeutics Program Division Of Cancer Treatme
-
Lunn George
Program Resources Inc./dyncorp. Laboratory Of Pharmaceutical Chemistry Nci-frederick Cancer Research
著作論文
- Analysis of perillic acid in plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection
- Reversed-phase high-performance liquid chromatography of 4-(2-pyridyl)-1-piperazinethiocarboxylic acid 2-[1-(pyridyl)ethylidene]hydrazide dihydrochloride (NSC 348977), a synthetic thiosemicarbazone with antitumor activity